Trials
Search / Trial NCT06429189

Home-Combo: an Online Home-based Combined Exercise Intervention for Women With Breast Cancer

Launched by GRUPO LUSÓFONA · May 20, 2024

Apply for Trial

Trial Information

Current as of March 14, 2025

Not yet recruiting

Keywords

Breast Cancer Home Based Exercise Functional Performance Body Composition Physical Activity Quality Of Life

ClinConnect Summary

Study setting The Home-Combo study will take place in the Algarve, and the sample will be recruited by medical referral from various public and private hospitals across the region.

The intervention design will consider the PA/exercise preferences, perceived barriers, and facilitators of women with BC. This information will be collected before the intervention through a mixed-methods qualitative study that will include a survey and focus groups. The intervention will be conducted online to ensure the participants' safety during the chemotherapy treatment phase, as they may have compromised ...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • • Breast cancer stage I-III diagnosis
  • • Scheduled to receive neoadjuvant or adjuvant chemotherapy
  • • Have acess to a computer
  • Exclusion Criteria:
  • • Medical conterindication to perform exercise or physical assessments due to concomitant comorbidity
  • • Non-controlled health conditions or diseases
  • • Psychological illness
  • • Currently enrolled in a structured exercise program
  • • Unable to complete the entire program (e.g., due to scheduled surgery or personal commitments)
  • • Pregnancy
  • • Worsening of clinical condition during intervention

Trial Officials

Pedro B. Júdice, PhD

Study Director

CIDEFES

Eliana V. Carraça, PhD

Study Director

CIDEFES

About Grupo Lusófona

Grupo Lusófona is a distinguished clinical trial sponsor dedicated to advancing healthcare through innovative research and development. Committed to enhancing patient outcomes, the organization specializes in the design and implementation of clinical studies across a range of therapeutic areas. With a strong emphasis on ethical practices and regulatory compliance, Grupo Lusófona collaborates with healthcare professionals and research institutions to foster scientific knowledge and improve treatment options. Their mission is to contribute to the global medical community by facilitating high-quality clinical trials that prioritize patient safety and efficacy.

Locations

Lisboa, , Portugal

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0